# PVH Corp. (PVH) — Financial Analysis

**Exchange:** NYSE  
**Coverage as of:** 2026-Q2  
**Updated:** 2026-05-27  
**Tier:** Free primer (step 2 of 19)  
**Sibling pages:** /stocks/PVH/thesis · /stocks/PVH/memo

## Financial Snapshot

---
source: coverage-next-full
ticker: PVH
step: 04
title: Financial Quality & Adversarial Sweep
created: 2026-05-27
---

### Step 04 — Financial Quality & Adversarial Sweep: PVH Corp. (PVH)

#### Key Findings
- **GAAP financials are significantly distorted:** FY2025 GAAP operating income ($231M, 2.6% margin) is not representative — three large non-cash/non-recurring items inflate SG&A: (1) $426M goodwill impairment Q1 FY2025, (2) ~$80M Growth Driver 5 restructuring, (3) SBC ~$44M. Adjusted operating income ~$730M (~8.2% margin) is the correct baseline [S1]
- **Recurring impairment pattern is a concern:** Three goodwill impairment events in 5 years ($879M FY2021, $417M FY2022, $426M FY2025) — totaling $1.7B — signals that PVH overpaid for acquisitions and/or brands have not performed to initial underwriting [S2]
- **Adversarial sweep:** China Xinjiang cotton controversy and the UEL designation are the most significant active risk factors. No active SEC enforcement, no material accounting fraud indicators, no significant short-selling thesis beyond operational challenges [S3]
- **Cash conversion is strong:** Free cash flow ($538M FY2025) consistently exceeds net income — a positive quality signal indicating reported earnings are conservative relative to true cash generation
- Net assessment: **Mixed** — underlying cash economics are healthy; the impairment cycle and GAAP distortions require investor sophistication

#### Implications for Thesis and Valuation
The goodwill impairment recurrence ($1.7B total since FY2021) is the primary financial quality red flag. Each impairment suggests the brands were worth less than the acquisition price — a verdict that the market has already rendered. However, the FCF story is clean: $500M+ per year in free cash flow funds the buyback program and reduces share count by ~10% per year. For valuation purposes, using non-GAAP EPS (~$10-11 in FY2024) is appropriate and is what the analyst consensus references.

#### Objective
Assess financial statement quality through GAAP vs. adjusted reconciliation, cash conversion analysis, balance sheet quality, and the Adversarial Research Sweep.

#### Narrative Analysis

##### GAAP vs. Adjusted: The Three Distortions

**Distortion 1: Goodwill Impairments ($426M in FY2025)**
In Q1 FY2025 (quarter ended May 4, 2025), PVH recognized a $426M goodwill impairment charge. This non-cash charge reduced net income by ~$426M but had zero impact on operating cash flow. The impairment was primarily related to the Asia-Pacific reporting unit, reflecting the China UEL designation and its impact on APAC growth prospects. This follows $417M in FY2022 (related to Heritage Brands) and $879M in FY2021 (COVID-era Heritage) [S2].

**Distortion 2: Growth Driver 5 Restructuring (~$80M in FY2025)**
PVH incurred approximately $80M in restructuring charges across FY2025 ($13M Q1, $45M Q2, $22M Q3) related to the Growth Driver 5 cost savings initiative. These are real cash costs but are non-recurring and should be analyzed separately from underlying business performance [S4].

**Distortion 3: Stock-Based Compensation ($44M in FY2025)**
SBC is a real economic cost (dilution) but is non-cash. At $44M/year on a ~48M share count, it represents roughly $0.90/share in annual dilution. This is relatively modest and does not distort the fundamental earnings picture significantly.

**Adjusted Financials (FY2025 Estimate)**
| Item | GAAP | Add-Back | Adjusted |
|------|------|----------|---------|
| Operating Income | $231M | +$426M impairment | ~$657M |
| | | +$80M restructuring | +$80M |
| Adjusted Operating Income | — | — | ~$737M |
| Adjusted Op. Margin | — | — | ~8.2% |

##### Cash Conversion Quality
PVH's FCF consistently exceeds reported net income — a positive quality indicator suggesting the business generates real cash even in years where GAAP net income is depressed by non-cash charges:

| Year | Net Income | Operating CF | CapEx | Free Cash Flow | FCF/NI Ratio |
|------|-----------|-------------|-------|---------------|-------------|
| FY2021 | $952M | $1,071M | ($268M) | $803M | 0.84x |
| FY2022 | $200M | $39M | ($290M) | ($251M) | neg |
| FY2023 | $664M | $969M | ($245M) | $724M | 1.09x |
| FY2024 | $599M | $741M | ($159M) | $582M | 0.97x |
| FY2025 | $25M | $680M | ($142M) | $538M | 21.5x |

FY2022 FCF was negative due to inventory build (supply chain disruption resolution) — a one-time event. The pattern for FY2023-FY2025 shows $538-724M in FCF, supporting the $500M+ annual buyback program.

CapEx has declined from $290M (FY2022) to $142M (FY2025) — a 51% reduction — reflecting the shift from physical store expansion to DTC digital investment and Growth Driver 5 infrastructure rationalization.

##### Balance Sheet Quality Assessment
**Goodwill and Intangibles ($5.1B of $11.7B assets = 44% of total assets)**
This is the primary balance sheet concern. PVH's balance sheet is heavily skewed toward legacy acquisition intangibles (Tommy Hilfiger and Calvin Klein brand names, customer relationships). If the brands underperform, additional impairments are possible. The Calvin Klein brand name alone is carried at ~$2.8B [S1].

**Inventory ($1.58B FY2025)**
Inventory increased from $1.42B (FY2023 year-end) to $1.58B (FY2025 year-end). Days inventory outstanding (DIO) = ~150 days on $3.8B COGS — reasonable for a seasonal fashion business. The FY2022 inventory spike ($1.80B) led to the negative FCF year.

**Net Debt (~$3.6B)**
Total debt $4.3B (StockAnalysis estimate) vs. cash $0.7B = net debt ~$3.6B. At ~$900-1,000M EBITDA, this is ~3.5-4x EBITDA. Not distressed, but limits financial flexibility. Debt is investment-grade rated; no near-term maturities that would force refinancing at higher rates.

##### Adversarial Research Sweep

**Active Short Theses / Risks Identified:**
1. **China UEL Escalation:** The February 2025 designation could escalate to formal import/export restrictions, effectively barring PVH from selling in China's $1-1.5B market. The company does not know what measures MOFCOM will impose [S3].
2. **Brand Positioning Squeeze:** Calvin Klein faces the "Goldilocks problem" — too expensive for Zara shoppers, not aspirational enough for LVMH shoppers. If the brand cannot find its identity, pricing power erodes.
3. **Goodwill Impairment Recurrence:** With $5.1B in intangibles remaining, the market may fear additional impairments if APAC (UEL) or Heritage underperforms. FY2026 impairments are possible.
4. **Tariff Creep:** PVH guided $195M gross tariff impact in FY2026 with 60% mitigation. If tariffs escalate further or mitigation falls short, EPS estimates face downside.
5. **Wholesale Channel Decline:** Department store traffic continues to erode. If wholesale declines faster than DTC grows, revenue may disappoint.

**No Active SEC Enforcement Found:** No SEC enforcement actions, accounting restatements, or fraud allegations identified in research. The Xinjiang cotton controversy is a sourcing/geopolitical issue, not an accounting issue.

**Activist/Short Sellers:** No prominent activist or short-seller campaign identified beyond general macro bears on consumer discretionary.

#### Evidence and Sources
- GAAP vs. adjusted reconciliation: XBRL data + company press releases
- Goodwill impairment history: XBRL GoodwillImpairmentLoss data, confirmed
- China UEL: MOFCOM announcement Feb 2025, news coverage
- Adversarial sweep: Web search for SEC enforcement, lawsuits, short theses

#### Assumption Register Updates
- A07 confirmed: Non-GAAP operating margin ~8.0-8.5% in FY2025 after adding back impairment and restructuring
- A10 confirmed: Net debt ~$3.6B

#### Open Questions and Data Gaps
1. Exact breakdown of restructuring charges: severance vs. facility costs vs. systems
2. Tax rate normalization: FY2025 effective tax rate distorted by impairment (non-deductible) — need FY2026 normalized rate
3. Additional goodwill at risk by reporting unit: Only APAC impaired in FY2025; Americas and EMEA carry significant goodwill that could be at risk

#### Source Index
| Source Tag | Document or URL | Section | Date | Notes |
|------------|----------------|---------|------|-------|
| [S1] | SEC XBRL / StockAnalysis.com | Financial statements | 2026-05-27 | Revenue, income, assets |
| [S2] | SEC XBRL GoodwillImpairmentLoss | Goodwill impairments | 2026-05-27 | $879M FY2021, $417M FY2022, $426M FY2025 |
| [S3] | MOFCOM / PVH 8-K Feb 2025 | China UEL designation | 2025-02-04 | Potential measures unknown |
| [S4] | PVH Q1-Q3 FY2025 8-Ks | Growth Driver 5 restructuring | 2025 | $13M+$45M+$22M charges |
| [S5] | StockAnalysis.com cash flow | FCF data FY2021-FY2025 | 2026-05-27 | Operating CF, CapEx, FCF |
| [S6] | Industry research | Adversarial sweep | 2026-05-27 | No SEC enforcement found |

## Deeper Financial Analysis

The fundamental tier ($1.00) adds 8 dimensions not included here:

- Revenue Breakdown — segment revenue, geographic mix, product-line margins
- Financial Trends — QoQ momentum, leading indicators, inflection points
- Balance Sheet — debt structure, dilution risk, working capital dynamics
- Capital Allocation — ROIC, buyback cadence, reinvestment efficiency
- Earnings Analysis — beats/misses, guidance vs actuals, transcript highlights
- Competitive Positioning — market share, pricing power, peer benchmarks
- Industry Context — TAM, sector tailwinds/headwinds, regulatory backdrop

**API endpoint:** GET /api/v1/research/PVH/fundamental

## Navigation

- Overview: /stocks/PVH
- Financials (this page): /stocks/PVH/financials
- Thesis: /stocks/PVH/thesis
- Investment Memo: /stocks/PVH/memo
- Coverage universe: /stocks